Companion Diagnostics Market (2nd Edition), 2014 - 2024

DUBLIN, June 16, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/bqwbck/companion) has announced the addition of the "Companion Diagnostics Market (2nd Edition), 2014 - 2024" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The Companion Diagnostics Market (2nd Edition), 2014 - 2024' report provides an extensive study of the growing market of companion diagnostics. The report differentiates personalized medicine diagnostics and companion diagnostics; it has separately defined these two closely associated markets. The research covers various aspects, such as advantages of personalized medicine over traditional medicine and the need for companion diagnostics. In addition to evaluating the marketed and pipeline companion diagnostic tests, the report also includes views on the current state of the companion drugs market.

One of the key objectives of this report is to understand the future evolution of the companion diagnostics market. The proprietary Companion Diagnostics Market Forecasting Model' allows the likely growth of companion diagnostics tests across various parameters to be predicted. The model, built over a ten year horizon, offers valuable insights on the following:

• Global market evolution, both in terms of volume (number of tests) and the associated sales value (USD billion)
• Regional variation, specifically in the US and European (Germany, Italy, France, Spain and the UK) markets
• Likely adoption of marketed / pipeline tests for specific biomarkers (e.g. EGFR, KRAS, ALK, HER2 and BRAF) till 2024
• Likely adoption of various marketed / pipeline tests for specific indications (e.g. metastatic non-small cell lung cancer, metastatic colorectal cancer, breast cancer and melanoma) till 2024

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. COMPANION DRUGS MARKET, 2013

5. GLOBAL MARKET FOR COMPANION DIAGNOSTICS, 2014 - 2024

6. REGIONAL MARKET FOR COMPANION DIAGNOSTICS, 2014 - 2024

7. PROFILES OF LEADING COMPANIES

8. ANALYSIS OF THERANOSTICS MARKET: STAKEHOLDERS AND BUSINESS MODELS

9. MARKET GROWTH DRIVERS

10. INTERVIEW TRANSCRIPTS

11. CONCLUSION

12. APPENDIX 1: TABULATED DATA

13. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

For more information visit http://www.researchandmarkets.com/research/bqwbck/companion

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net